#GLP1 #Diabetes #Type2Diabetes #ObesityTreatment #OralTherapy #EliLilly #Biotech #ClinicalTrials #HealthcareInnovation #Endocrinology #CardiometabolicHealth #WeightLoss #Pharmaceuticals #InvestorInsights #PatientCare #MedTech #LifeSciences #HealthTech #Semaglutide #GLP1 #EliLilly #Wegovy #Zepbound #Ozempic #Mounjaro #NovoNordisk #Sanofi # #Orforglipron #Marshallcapps #FDA #Regulation #Pharma #Healthcare #Biotech To view or add a comment, sign in Recent observational data suggest that liraglutide, semaglutide, and dulaglutide may offer comparable cardiovascular and kidney benefits in people with type 2 diabetes, while also delivering weight loss support
The team includes gastroenterologists, GI registered dietitians, gut-brain specialists and other GI providers who work together to ensure youre getting well-rounded and integrated care
Whether or not you experience a side effect, how often it occurs and its severity may be different from these studies
Do you find expensive supplements sitting unused in your cabinet because they simply dont deliver results
Watch for hiccups that do not stop, and bring them up with your clinician so they can decide if evaluation or a medication change is needed
It may deliver short-term relief in highly selected cases (e.g., very elderly or those with major comorbidity, or a rare, well-localized peripheral trigger), but recurrence is common and there is a meaningful risk of anesthesia dolorosa (painful numbness)